Evrópusambandið - tékkneska - EMA (European Medicines Agency)

novartis europharm limited  - indacaterol, mometasone furoate - astma - léky na obstrukční onemocnění dýchacích cest, - bemrist breezhaler is indicated as a maintenance   treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.

Evrópusambandið - tékkneska - EMA (European Medicines Agency)

novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - léky na obstrukční onemocnění dýchacích cest, - maintenance treatment of asthma in adults whose disease is not adequately controlled.

Evrópusambandið - tékkneska - EMA (European Medicines Agency)

novartis europharm limited - crizanlizumab - anémie, kosáčková buňka - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Evrópusambandið - tékkneska - EMA (European Medicines Agency)

novartis ireland ltd - ofatumumab - roztroušená skleróza, relaps-remitentní - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

Evrópusambandið - tékkneska - EMA (European Medicines Agency)

novartis europharm limited  - capmatinib dihydrochloride monohydrate - karcinom, plicní jiná než malobuněčná - antineoplastická činidla - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.

Tékkland - tékkneska - SUKL (Státní ústav pro kontrolu léčiv)

novartis s.r.o., praha array - 4294 cyklosporin - měkká tobolka - 100mg - cyklosporin

Tékkland - tékkneska - SUKL (Státní ústav pro kontrolu léčiv)

novartis s.r.o., praha array - 4294 cyklosporin - měkká tobolka - 25mg - cyklosporin

Tékkland - tékkneska - SUKL (Státní ústav pro kontrolu léčiv)

novartis s.r.o., praha array - 4294 cyklosporin - měkká tobolka - 50mg - cyklosporin

Tékkland - tékkneska - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

novartis animal health d.o.o. - florfenikol - roztok pro podání v pitné vodě - amphenicols - prasata

Evrópusambandið - tékkneska - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - kyselina zoledronová - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - léky na léčbu nemocí kostí - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. léčba osteoporózy spojené s dlouhodobou terapií systémovými glukokortikoidy u postmenopauzálních žen a u mužů se zvýšeným rizikem zlomenin. léčba pagetovy choroby kostí.